Unlocking the Body’s Defenses The Promise of Melanoma Vaccines [Video]

“Could a vaccine treat cancer? Texas Oncology is testing an mRNA Moderna shot for melanoma. In the U.S., 23 people are diagnosed with melanoma per 100,000 each year, with two deaths. The vaccine uses the patient’s tumor and immune system to fight skin cancer recurrence, marking a potential shift from COVID-19 to cancer in Moderna’s mRNA vaccines. Texas Oncology in Austin and Dallas are among 165 global sites testing this vaccine for melanoma, with similar trials for colon and pancreatic cancers. The study combines Merck’s Keytruda with the Moderna vaccine, offering personalized immunotherapy. Patients receive surgery and a year of immunotherapy, followed by nine vaccines over four to six months. The goal? To remain cancer-free. Melanoma, the ‘bad guy’ of skin cancers, spreads unpredictably, often to vital organs. The trial aims to enroll 1,089 participants globally, targeting stage 2, 3, or 4 melanoma patients. Results from phase 2 showed a 44% decrease in recurrence or death compared to standard treatment. If phase 3 proves even more effective, FDA approval could follow. Regular skin checks are crucial for early detection. Remember: ‘Birthday suit on your birthday.’ Prevention includes wearing daily SPF 15+ sunscreen, skin-protective clothing, and avoiding the sun during peak hours.” Like and Subscribe for more updates.